The Phase 1 ELIMINATE-B study is currently enrolling HBeAg-negative chronic hepatitis B patients at world-class sites in Moldova, Hong Kong, and New Zealand, and imminently commencing in the U.S.

The FDA has cleared the investigational new drug (IND) application of GLIX1, a first-in-class small molecule targeting DNA repair vulnerabilities, offering a potential therapy for glioblastoma. 1 With ...

Pfizer's beleaguered obesity strategy has hit another setback as the pharma jettisoned its third and final GLP-1 agonist, citing poor data and tough competition. | Pfizer has jettisoned yet ...

A disturbing theory about the Fermi Paradox suggests that the silence of the universe is a warning for us.

Nuclear enrichment startup General Matter officially announced plans Tuesday to build a $1.5 billion uranium enrichment facility at the decommissioned Paducah Gaseous Diffusion Plant within the U ...

Revisiting Phase 1 of the MCU in 2025 makes the mega-franchise's early days seem quite different in hindsight.

AbbVie is ending development of an IL-1 asset as a monotherapy in ulcerative colitis after a phase 2 study revealed insufficient efficacy results.

This marks Phase 1 Equity's fifth practice added in 2025, its 14 th doctor to join the platform and brings total locations to 22.

TAR-200 for Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 Study. If you have the appropriate software installed, you can ...